Mount Vernon Associates Inc Teva Pharmaceutical Industries LTD Transaction History

Mount Vernon Associates Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 24, 2020	SELL	$6.53 - $10.72 $65,352 - $107,285	-10,008 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$6.16 - $9.6 $1,848 - $2,880	-300 Reduced 2.91%	10,008 $69,000
Q2 2019 Jul 30, 2019	SELL	$8.12 - $15.72 $76,644 - $148,381	-9,439 Reduced 47.8%	10,308 $95,000
Q2 2019 Jul 25, 2019	BUY	$8.12 - $15.72 $72,584 - $140,521	8,939 Added 82.71%	19,747 $182,000
Q1 2019 Apr 25, 2019	BUY	$15.58 - $20.01 $7,790 - $10,005	500 Added 4.85%	10,808 $169,000
Q3 2018 Oct 22, 2018	SELL	$21.06 - $25.65 $21,060 - $25,650	-1,000 Reduced 8.84%	10,308 $222,000
Q2 2018 Jul 27, 2018	BUY	$16.77 - $24.71 $14,271 - $21,028	851 Added 8.14%	11,308 $275,000
Q1 2018 Apr 19, 2018	SELL	$16.68 - $22.07 $4,170 - $5,517	-250 Reduced 2.33%	10,457 $179,000
Q4 2017 Jan 24, 2018	SELL	$11.23 - $19.1 $13,094 - $22,270	-1,166 Reduced 9.82%	10,707 $203,000
Q3 2017 Oct 24, 2017	BUY	$15.41 - $32.17 $182,962 - $381,954	11,873	11,873 $209,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Mount Vernon Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Mount Vernon Associates Inc with notifications on news.